Log in
Enquire now
‌

US Patent 11535669 Fusion constructs and methods of using thereof

Patent 11535669 was granted and assigned to Precigen on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Precigen
Precigen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115356690
Patent Inventor Names
Helen Sabzevari0
Simon Metenou0
Rutul R. Shah0
ChangHung Chen0
Date of Patent
December 27, 2022
0
Patent Application Number
165069810
Date Filed
July 9, 2019
0
Patent Primary Examiner
‌
Vanessa L. Ford
0
CPC Code
‌
A61K 38/2013
0
‌
A61K 38/1793
0
‌
C07K 2319/00
0
‌
C07K 14/71
0
‌
C07K 14/495
0
‌
C07K 14/55
0
‌
C07K 14/705
0

Provided herein is a composition comprising a fusion protein or a fragment or a variant thereof comprising an anti-PD1 antibody or a fragment/variant thereof and a TGF-β trap. Provided herein is a composition comprising a fusion protein or a fragment thereof or a variant thereof comprising an anti-PD1 antibody or a fragment/variant thereof and a ADA2 polypeptide. Also provided herein are methods of using the composition in treating cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11535669 Fusion constructs and methods of using thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us